We studied acid secretory responses to exogenous pentagastrin and to exogenous and endogenous gastrin in 12 stable cirrhotic subjects with portacaval shunt, 12 unshunted cirrhotics, and 12 normal subjects. Basal and stimulated serum gastrin concentrations as well as basal and maximum acid outputs were similar in the three groups. At low doses ofeither exogenous pentagastrin or gastrin-17 (G17), cirrhotics with portacaval shunt secreted significantly greater amounts of gastric acid than unshunted subjects. After low doses of intragastric peptone, cirrhotics with portacaval shunt secreted significantly more acid than unshunted cirrhotics and normal subjects. At each measured serum gastrin concentration after either exogenous G17 or intragastric peptone meals, cirrhotics with portacaval shunt secreted more acid than the unshunted control groups and their dose-response curve was significantly shifted to the left. Thus, in cirrhotic patients with portacaval shunt, gastric acid secretion is abnormally sensitive to both exogenously administered or endogenously released gastrin.
Introduction
The major life-threatening complication of cirrhosis of the liver is upper gastrointestinal bleeding due to esophageal bleeding or peptic ulcer (1) . In order to prevent recurrent bleeding from esophageal varices, various types of surgical procedures to decompress the portal circulation have been utilized; the most common of these is the portacaval shunt (2) . After portacaval shunt in dog, gastric acid secretion increased both in the basal state and in response to enteral and parenteral stimulants (3) (4) (5) . The effects of portacaval shunt on basal and maximal acid secretion in humans reveal confficting observations; some report no change (6) , and others an increase (7) . Although acid secretion in the presence of intragastric meals has not been tested in cirrhotic subjects, jejunal distension with a meal or a balloon sig-nificantly increased gastric acid secretion in those with a portacaval shunt (+PCS¢),' while in normal subjects (N) or unshunted cirrhotics (-PCS,) jejunal distension was without effect (6, 8) . The mechanism responsible for altered secretory responses in humans after portacaval shunt is unknown.
During a series ofexperiments designed to examine the effects of nutrient and nonnutrient jejunal meals in +PCSC and -PCSc (8) , we observed that gastric acid secretion in +PCSc was much more sensitive to intravenous infusion of the COOH-terminal pentapeptide of gastrin, pentagastrin, than -PCSc and N (9).
Since gastrin fragments containing less than eight amino acids are preferentially inactivated during hepatic transit (10) , the differences between +PCSc and -PCSc may have been secondary to higher blood levels of pentagastrin in the shunted group. Therefore, the purpose of this study was to determine whether +PCSc were more sensitive to endogenously released gastrin or to an exogenous gastrin, which is not preferentially metabolized in the liver (10), compared with -PCSc as well as N.
Methods
Subjects. 12 . Measurement ofacid secretion in response to peptone. On a separate day and after measuring basal secretion for 30 min, liquid test meals, 500 ml each, containing peptone (Bacto-Peptone; Difco Laboratories, Detroit, MI) were given in increasing order of concentration (0, 0.5, 1.0, 2.0, 4.0, and 8.0% wt/vol) adjusted to 310 mosmol/kg and pH 7.0 by the addition of NaCl and 4 N HC1, respectively. To control for the effect of distension alone, the zero dose contained 0.15 M NaCl adjusted to pH 7.0. The meal was instilled in the stomach through the nasogastric tube by gravity over 3 min. Gastric acid secretion was measured for 30 min by in vivo automatic intragastric titration at pH 7.0 by the addition of 0.5 M NaOH (15) . 30 min after the instillation of each meal, the gastric contents were completely aspirated, the recovered volumes measured to the nearest milliliter, the stomach lavaged with 100 ml of 0.15 M NaCl, and the next meal instilled. Earlier studies indicated that intragastric administration of 8% peptone resulted in greatest secretory response and that the secretory responses to each dose were not significantly altered when the titration time of 30 min was extended to 45 min (14) . Furthermore, the acid secretory responses did not differ significantly whether the test meals were given sequentially on a single day or individually in random order on separate days (14) .
Measurement of serum gastrin. Serum gastrin was measured in response to both intravenous infusion ofG17 and the intragastric peptone meals. Venous blood was obtained at 30-min intervals through an indwelling intravenous plastic catheter (Abbocath-T 20 gauge; Abbott Hospitals, Inc., North Chicago, IL). The blood was allowed to clot for 30 min, centrifuged at 4°C, and sera were stored at -20°C for radioimmunoassay. Sera were measured in duplicate and the averages used. The antibody, 1611, was raised in rabbits immunized with G17 conjugated to bovine serum albumin (16) . It was used in a final concentration of 1 :250,000. This antibody is highly specific for both forms of gastrin (G17 and G34) and has < 3% cross-reactivity with porcine cholecystokinin (16) . With this antiserum, human G17 and human big gastrin (G34)
were measured on a nearly equimolar basis (I17). 
Results
Effect ofpentagastrin. Basal acid outputs were 2.5±0.7 mmol/ 0.5 h in +PCSc, 1.6±0.3 mmol/0.5 h in -PCS,, and 1.8±0.3 mmol/0.5 h in N. These differences were not significant. Maximal acid outputs were similar in the three groups (Fig. 1) . In response to low doses of pentagastrin, acid secretion was significantly (P < 0.01) greater in +PCSc compared with the two unshunted control groups. The secretory rates in response to each dose of pentagastrin were similar in -PCSc and N (Fig. 1) . The mean dose of pentagastrin that was required to elicit one-half maximal gastric secretory responses was significantly lower in +PCS, compared with both the -PCSc and N; regardless of whether the absolute or the basal-corrected values for gastric acid secretion were examined (Table I) . No significant differences ofthe pentagastrin ED50s were observed between -PCSc and N.
Effect of GJ 7. Basal acid outputs were not significantly (P (Fig. 2) . The maximal acid outputs to G17 were almost identical in N and -PCSc, and were similar compared with the mean maximum acid output in the +PCSc (Fig. 2) . Gastric acid secretion in response to the three lowest doses of G17 was significantly (P < 0.01) greater in the +PCSc group compared with the two -PCSc groups (Fig. 2) . Serum gastrin concentrations at basal and during intravenous infusion of G17 were similar in +PCSc, -PCSc, and N (Fig. 2,   inset ). When the acid secretory responses were expressed in terms ofthe circulating serum gastrin concentrations (Fig. 3) , the doseresponse curve in the +PCSc group was significantly shifted to the left. The plasma gastrin concentration following G17 that resulted in one-half maximal gastric acid secretion (EC3o-G17) was 19.5±2.3 pM in +PCSc and significantly (P < 0.01) lower 15 . , / / I'll pmol/kg per h) (Fig. 4 B) . Effect ofpeptone meals. On the meal test days, basal acid secretion was similar in cirrhotics with portacaval shunt com- to peptone were almost identical in the three groups (Fig. 5) . After instillation of 0.15 M NaCl alone, as a control for distension, gastric acid secretion was comparable in the three groups (Fig. 5) . However, as observed with exogenous G17 infusions, the dose-response curve to peptone was also significantly (P < 0.01) shifted to the left in those with portacaval shunt. For example, the lowest dose of peptone (0.5%) increased acid secretion to 58% of the maximal response in +PCSC compared with 30% in -PCS, and 28% in N (Fig. 5) . Serum gastrin concentrations before and after 0, 0.5, 1.0, and 2.0% peptone were similar in the three groups (Fig. 5, inset) . The gastrin responses to 4.0 and 8.0% peptone were numerically, yet not significantly (P > 0.5), greater in the two unshunted control groups compared with +PCSC.
When the individual serum gastrin concentrations after the test meals were related to the individual acid outputs, the curve of the +PCSc. was significantly shifted to the left (Fig. 6) . For example, a serum gastrin concentration of 35 pM was associated with a near maximum secretory response to the meal in the +PCSc, while in both the -PCSc and N the secretory response was 58% of maximum. The test meal that contained 0.15 M NaCl (0% peptone) produced serum gastrin concentrations and acid secretory rates that were similar in the three groups (Fig.  6 , the lowest values in each group). However, at each gastrin concentration after the peptone meals, +PCSc secreted more acid than either ofthe two unshunted groups (Fig. 6) . The plasma gastrin concentration after the peptone meals that resulted in one-half maximal acid secretion (EDw-peptone) was 22.8±1.8 pM in +PCSc and was significantly (P < 0.01) lower than the ED50-peptone in the -PCSc (31.7±2.6 pM) and in N (34.9±2.6 pM).
Discussion
The results of this study indicate that (a) Basal gastric acid secretion was slightly, yet not significantly, greater in +PCSC compared with -PCSc and N; (b) Maximal acid secretion in response to either pentagastrin, human gastrin 17-I (G17), or protein meals was similar in +PCSC, -PCSc, and N; (c) Gastric acid secretion was significantly more sensitive to exogenously administered pentagastrin or G17, as well as to endogenously released gastrin in +PCSC, compared with -PCSc and N.
Maximal acid output in response to histamine was increased in dog after portacaval anastomosis (5) . Prior studies in humans using histamine as the gastric agonist (6) , and the present study, indicate that maximal acid output either in response to pentagastrin or GI 7 was similar in +PCSc compared with -PCSc and N. These observations indicate that the total parietal cell mass is not increased in humans after portacaval shunt (12). Acid secretion in response to an intragastric meal was increased in dogs with separated gastric (Dr. Heidenhain) pouches after portacaval transposition (5), but has not previously been studied in humans. Our results demonstrate that acid output in response to a maximally stimulating dose ofan intragastric peptone meal (14) was similar in +PCSC, -PCSc, and in N.
At pharmacologic serum gastrin concentrations, gastric acid secretion was similar in the shunted and unshunted subjects, while at physiological serum gastrin concentrations of 50 pM and less (20) , gastric acid secretion was significantly more sensitive to circulating gastrins in patients with portacaval shunt. It appears that the parietal cell in cirrhotic patients after portacaval shunt is exceedingly sensitive to gastrin. Increased sensitivity of the gastric mucosa to human gastrin has also been reported in the rat after portacaval shunt (21) .
In +PCSc, but not in -PCSc or N, jejunal distension with a balloon or a hyperosmolar solution resulted in significant secretory responses (6, 8) . It has been suggested that a humoral substance may be released from the small intestine that enhances gastric acid secretion when it bypasses the liver (22) . The partial isolation of a nongastrin agonist of gastric acid secretion from the porcine small intestine referred to as the intestinal phase hormone or entero-oxyntin has been described (22, 23) . It is possible that such a humoral agent, secreted by the human proximal small intestine and normally inactivated by the liver, functions as an agonist of acid secretion after portacaval shunt. This would explain the observation that in +PCSc the administration of low doses of peptone meals, that did not alter serum gastrin concentrations, resulted in significant increases in gastric acid secretion. Also, since stimulants of acid secretion, such as histamine and gastrin, resulted in a potentiated response when administered in combination (24) , it is possible that an intestinal stimulant contributed to the increased sensitivity to intravenous pentagastrin and G17, as well as to the peptone meals.
Portacaval shunt diverts mesenteric blood directly into the systemic circulation, bypassing the liver, which is one of many sites involved in gastrin metabolism (25) . Therefore, higher levels of gastrin in the +PCSc could have mimicked the observed increased sensitivity. However, circulating gastrin levels were similar during intravenous infusion ofG17 in those with and those without portacaval shunt. Also, gastrin fragments containing less than eight amino acids are preferentially removed by hepatic transit (10) . Therefore, small circulating forms of gastrin not measurable by radioimmunoassay could result in the observed increased sensitivity to G17 and the peptone meals, as well as account for the slightly elevated basal secretion. If increased concentrations of small circulating gastrin fiagments at basal were to cause the increased sensitivity to G 17, the additive effect of those molecular forms together with exogenous G17 could mimic the increased sensitivity. After subtracting the basal values, which, in part, may be due to small and large circulating forms of gastrin molecules, +PCSC were still more sensitive than the unshunted control groups. This suggests that increased concentrations of small gastrin fiagments did not contribute to the hypersensitivity of +PCSC that was observed in response to exogenous G17. However, it is possible that peptone meals induced the release of small molecular forms of gastrin that were not detected by the radioimmunoassay. These gastrin fragments that are not removed by hepatic transit (10) could contribute to the increased sensitivity of gastric acid secretion to peptone meals in the +PCSc. In summary, the results of this study indicate that gastric acid secretion is very sensitive to exogenously administered and endogenously released gastrin in +PCSc compared to -PCSc and N. Increased sensitivity to gastrin may be due to the presence of an intestinal agonist of acid secretion that is normally inactivated within the liver. Other factors that may be released by intragastric peptone (e.g., small gastrin fragments) may also contributre to the increased sensitivity of meal-stimulated gastric acid secretion in +PCSc.
